National Cancer Institute
Toward Translation of Nanotechnology Cancer Interventions (R01 Clinical Trial Not Allowed)
Deadline
November 15, 2027
Eligibility
United States, Foreign components allowed
Funding Amount
Unlock to view
Grant Overview
Toward Translation of Nanotechnology Cancer Interventions (R01 Clinical Trial Not Allowed) is a research funding opportunity offered by National Cancer Institute covering areas such as Cancer, Nanotechnology, Translational Research, Biomedical Engineering for applicants in United States, Foreign components allowed. The application deadline is November 15, 2027.
Researchers, universities, institutions and eligible organizations should review the funder requirements, geographic eligibility, research focus and deadline before preparing an application.
Focus Areas
Geographic Eligibility
- •United States
- •Foreign components allowed
Before You Apply
Confirm the final deadline, applicant requirements, funding conditions and submission instructions on the official funder website before submitting an application.